The primary cell market was worth US$ 1.9 billion in 2021.
The primary cell market is expected to register a CAGR of 9.2% by 2032.
The rising frequency of cancer cases, rising cancer research activities, and cancer research funding are all significant factors for the growth of the primary cell market.
North America is the principal contributor to the global primary cell market. Rigorous research activities across the region drives the demand for primary cell.
Cell biologics, Stem Cell Technologies, Thermo Fisher Scientific, Lonza Group are few prominent players active in the market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved